Tekla Life Sciences Investors Ownership
$18.18
4.30%
NYSE, Oct 09, 04:10 pm EDT.
Closed.
Tekla Life Sciences Investors Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Parametric Portfolio Associates LLC
|
961.316k | 3.20% | +90.404k | Jun 30 2026 |
| 2 |
Penserra Capital Management LLC
|
838.890k | 2.80% | +32.002k | Jun 30 2026 |
| 3 |
Morgan Stanley Smith Barney LLC
|
791.275k | 2.64% | +111.699k | Jun 30 2026 |
| 4 |
LPL Financial LLC
|
514.161k | 1.71% | +35.359k | Jun 30 2026 |
| 5 |
Raymond James & Associates, Inc.
|
466.299k | 1.55% | +17.329k | Jun 30 2026 |
|
1
Parametric Portfolio Associates LLC
|
3.20%
961.316k
|
|
2
Penserra Capital Management LLC
|
2.80%
838.890k
|
|
3
Morgan Stanley Smith Barney LLC
|
2.64%
791.275k
|
|
4
LPL Financial LLC
|
1.71%
514.161k
|
|
5
Raymond James & Associates, Inc.
|
1.55%
466.299k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 11.91% of Tekla Life Sciences Investors, with Parametric Portfolio Associates LLC the biggest at 3.20%, followed by Penserra Capital Management LLC (2.80%) and Morgan Stanley Smith Barney LLC (2.64%). |
Recent Tekla Life Sciences Investors Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 12 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 09 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 05 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 30 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 24 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 17 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 12 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 09 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 05 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 30 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 24 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 17 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
